Taris Biomedical LLC:企業のM&A・事業提携・投資動向

◆英語タイトル:Taris Biomedical LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1992
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:105
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Taris Biomedical LLC – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Taris Biomedical LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Taris Biomedical LLC since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Taris Biomedical LLC’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Taris Biomedical LLC. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Taris Biomedical LLC’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Taris Biomedical LLC and its subsidiaries since 2007.
- Information about key financial and legal advisors for Taris Biomedical LLC’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Taris Biomedical LLC’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 4
LIST OF TABLES 5
LIST OF FIGURES 5
TARGETS AND PARTNERS 6
PARTNERSHIP 7
Partnership – Overview 7
Partnership – Deal reports 8
CAPITAL RAISING 40
Capital Raising – Overview 40
Capital Raising – Deal reports 41
PRIVATE EQUITY & OWNERSHIP 82
Private Equity and Ownership – Overview 82
Private Equity and Ownership – Deal reports 83
APPENDIX 95
Contact Us 95
About MarketLine Financial Deals Database 95
Deal Definition and Methodology 97
About MarketLine 104

List of Tables
Table 1: Taris Biomedical LLC partnership volume and value trend (2014-YTD2018)
Table 2: Taris Biomedical LLC partnership trend by key deal type (2014-YTD2018)
Table 3: Taris Biomedical LLC capital raising volume and value trend (2014-YTD2018)
Table 4: Taris Biomedical LLC capital raising by deal type (2014-YTD2018)
Table 5: Taris Biomedical LLC private equity and ownership volume and value trend (2014-YTD2018)
Table 6: Taris Biomedical LLC private equity and ownership activity by deal type (2014-YTD2018)

List of Figures
Figure 1: Taris Biomedical LLC partnership volume and value trend (2014-YTD2018)
Figure 2: Taris Biomedical LLC partnership trend by key deal type (2014-YTD2018)
Figure 3: Taris Biomedical LLC capital raising volume and value trend (2014-YTD2018)
Figure 4: Taris Biomedical LLC capital raising by deal type (2014-YTD2018)
Figure 5: Taris Biomedical LLC private equity and ownership volume and value trend (2014-YTD2018)
Figure 6: Taris Biomedical LLC private equity and ownership by deal type (2014-YTD2018)

★海外企業調査レポート[Taris Biomedical LLC:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SuanFarma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary SuanFarma SA (SuanFarma Group) is a drug development company that offers production, development, and marketing of raw materials and finished dosage forms. The company’s products portfolio includes amoxiciline capsules, enalapril tablets, colistin methanesulphonate, azitromicine film coated …
  • University of Pennsylvania-医療機器分野:企業M&A・提携分析
    Summary University of Pennsylvania (UOP) is an educational university that provides distance learning facilities for professional courses. The university offers courses such as art and archaeology, accounting, biochemistry, bioengineering, biomedical graduate studies, city and regional planning, cri …
  • Connecticut Municipal Electric Energy Cooperative:企業の戦略的SWOT分析
    Connecticut Municipal Electric Energy Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competi …
  • Union Electrica SA:企業の戦略的SWOT分析
    Union Electrica SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Erin Energy Corp (ERN):企業の財務・戦略的SWOT分析
    Summary Erin Energy Corp (Erin Energy), formerly CAMAC Energy Inc, a subsidiary of CAMAC Energy Holdings Ltd, is an oil and gas company that develops and produces oil and gas assets. The company's portfolio includes seven licenses in four countries and covers an area of approximately 19,000 sq km of …
  • Omega Protein Corporation:企業の戦略・SWOT・財務分析
    Omega Protein Corporation - Strategy, SWOT and Corporate Finance Report Summary Omega Protein Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Glidewell Laboratories:企業の戦略的SWOT分析
    Glidewell Laboratories - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Piramal Enterprises Ltd (PEL):企業の財務・戦略的SWOT分析
    Piramal Enterprises Ltd (PEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Red Electrica de Espana SA (REE)-エネルギー分野:企業M&A・提携分析
    Summary Red Electrica de Espana, S.A. (REE), a subsidiary of Red Electrica Corporacion S A. is a power transmission company. The company is involved in electricity transmission and other related operations through its transmission network. It manages the high-voltage transmission grid and is also re …
  • Modern Water plc (MWG):企業の財務・戦略的SWOT分析
    Summary Modern Water Plc (Modern Water) is a clean technology company that develops and supplies water monitoring systems. The company owns, installs and operates membrane technologies, develops and supplies systems for water monitoring. Its membrane process division utilizes forward osmosis technol …
  • Cogstate Ltd (CGS):企業の財務・戦略的SWOT分析
    Summary Cogstate Ltd (Cogstate) is a cognitive assessment company that provides technology solutions. The company offers scientific consulting, precision recruitment and computerized assessment, among others. Its clinical trail solutions include computerized cognitive assessment, cogstate prescreen, …
  • Tyson Fresh Meats Inc:戦略・SWOT・企業財務分析
    Tyson Fresh Meats Inc - Strategy, SWOT and Corporate Finance Report Summary Tyson Fresh Meats Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Star Gas Partners L.P.
    Star Gas Partners L.P. - Strategy, SWOT and Corporate Finance Report Summary Star Gas Partners L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Rubicon Research Pvt Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Rubicon Research Pvt Ltd (Rubicon), a subsidiary of Everstone Capital Management, is a drug delivery technology company that develops, manufactures and markets next-generation pharmaceutical products. The company’s products include central nervous system, cardiovascular, cough, cold and anti …
  • McWane Inc:企業の戦略的SWOT分析
    McWane Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Curemark LLC-医療機器分野:企業M&A・提携分析
    Summary Curemark LLC (Curemark) is a biopharmaceutical company that offers development of novel therapies. The company develops novel therapies to treat serious diseases for which there are limited treatment options. It provides CM-AT, CM-4612, CM-PK, CM-182, and CM-1212 drugs. Curemark’s product ca …
  • China UnionPay Company Ltd:企業の戦略・SWOT・財務情報
    China UnionPay Company Ltd - Strategy, SWOT and Corporate Finance Report Summary China UnionPay Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Distil plc:企業の戦略・SWOT・財務情報
    Distil plc - Strategy, SWOT and Corporate Finance Report Summary Distil plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Space Exploration Technologies Corp:戦略・SWOT・企業財務分析
    Space Exploration Technologies Corp - Strategy, SWOT and Corporate Finance Report Summary Space Exploration Technologies Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • HORNBACH Holding AG & Co. KGaA:企業の戦略・SWOT・財務分析
    HORNBACH Holding AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report Summary HORNBACH Holding AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆